United Laboratories International (ULIHF) Projected to Release Quarterly Earnings on Monday

United Laboratories International (OTCMKTS:ULIHF) is projected to release its results after the market closes on Monday, August 31st. Analysts expect the company to announce earnings of $0.0191 per share and revenue of $818.7220 million for the quarter.

United Laboratories International Stock Performance

Shares of ULIHF opened at $1.14 on Friday. The firm has a 50-day simple moving average of $1.23 and a two-hundred day simple moving average of $1.36. United Laboratories International has a 1-year low of $1.14 and a 1-year high of $1.70.

United Laboratories International Company Profile

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules.